These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18377610)

  • 1. Dihydroxyacetone: a safe camouflaging option in vitiligo.
    Rajatanavin N; Suwanachote S; Kulkollakarn S
    Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camouflaging vitiligo with dihydroxyacetone.
    Hsu S
    Dermatol Online J; 2008 Aug; 14(8):23. PubMed ID: 19061581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroxyacetone in a new formulation--a powerful therapeutic option in vitiligo.
    Fesq H; Brockow K; Strom K; Mempel M; Ring J; Abeck D
    Dermatology; 2001; 203(3):241-3. PubMed ID: 11701979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
    Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camouflaging Agents for Vitiligo Patients.
    Hossain C; Porto DA; Hamzavi I; Lim HW
    J Drugs Dermatol; 2016 Apr; 15(4):384-7. PubMed ID: 27050692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
    Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
    Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ; Dogra S; Parsad D; Kumar B
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the 308-nm excimer laser for the treatment of vitiligo.
    Hadi SM; Spencer JM; Lebwohl M
    Dermatol Surg; 2004 Jul; 30(7):983-6. PubMed ID: 15209787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of the sun protection factor provided by dihydroxyacetone.
    Faurschou A; Wulf HC
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):239-42. PubMed ID: 15379873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropigmentation: tattooing for the treatment of lip vitiligo.
    Singh AK; Karki D
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):988-91. PubMed ID: 19481511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.